10-year outcomes of technically unresectable oral cancers with neoadjuvant chemotherapy: Real-world data and implications for clinical practice. Tislelizumab plus chemotherapy as induction treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results